We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nitric Oxide Holds Benefits for Intensive Care Patients

By HospiMedica International staff writers
Posted on 16 Oct 2011
A new study suggests that the body's production of nitric oxide (NO) in response to low oxygen levels could improve the recovery of critically ill patients in intensive care.

Researchers at University College London (UCL; United Kingdom) and the University of Warwick (United Kingdom) conducted a study that involved blood samples and results collected from 198 trekkers and 24 climbers (including doctors and scientists) that participated in the 2007 Caudwell Xtreme Everest (CXE) expedition. More...
Using an integrated biochemical/whole-body physiology approach, the researchers were able to show that nitrite and nitrate--plasma biomarkers of NO production--and activity (cGMP) are elevated on acclimatization to high altitude, while S-nitrosothiols are initially consumed, suggesting multiple NOs contribute to improve hypoxia tolerance by enhancing NO availability.

The results suggest that NO is an integral part of the human physiological response to hypoxia, a finding that may be of relevance not only to healthy subjects exposed to high altitude, but also to patients in whom oxygen availability is limited by diseases affecting the heart, lung, or vasculature. The results also show that NO production and activity are elevated in people who live at near sea-level altitudes that ascend to altitude, leading to changes in blood flow in the smallest blood vessels. The results are also consistent with earlier data from residents of the Tibetan plateau, showing their normal NO levels to be much elevated compared to people living near sea-level. The study was published in the October 6, 2011, issue of Scientific Reports.

“By taking blood samples from hypoxic, but otherwise healthy, individuals we have been able to show that the body's natural response to low oxygen availability is to increase the production of nitric oxide,” said joint lead author Denny Levett, MD, of the UCL Center for Altitude, Space, and Extreme Environment Medicine. “Thus, elevated NO occurs not just in those who live at high altitudes permanently, but also in lowlanders who are trying to adapt to high altitude conditions.”

NO is a ubiquitous signaling molecule produced through the metabolism of L-arginine by nitric oxide synthases (NOS). Its formation is crucial for the control of blood pressure, blood flow, and other vital bodily functions; amongst these, it is an important antioxidant, and a regulator of intermediary metabolism and cellular energy production by mitochondria.

Related Links:

University College London
University of Warwick


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Wound Irrigation Solution
Prontosan®
New
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.